ArticleThe journal of physical chemistry. B2025
Mechanistic Insights into Lipooligourea-Lipid Membrane Interactions.
Article in The journal of physical chemistry. B, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Monocaprin, Monolaurin, and Monomyristin EradicatePharmaceuticals (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Understanding how synthetic peptidomimetics interact with bacterial membranes is key to developing next-generation antimicrobials. In this study, we investigate the membrane-disruptive behavior of C10-OU4, a cationic lipooligourea foldamer that mimics the amphiphilic architecture of antimicrobial lipopeptides. Using a multitechnique approach─Langmuir monolayer analysis, quartz crystal microbalance with dissipation monitoring (QCM-D), and attenuated total reflection-Fourier transform infrared spectroscopy (ATR-FTIR)─we probe the concentration-dependent interactions of C10-OU4 with lipid membranes that model Gram-positive bacterial membranes. At low concentrations (1 μM), C10-OU4 adsorbs to the membrane surface, inducing minor structural perturbations limited to the polar headgroup region. Increasing the concentration to 5 μM results in significant acyl chain disorder, partial membrane solubilization, and likely, micelle-like aggregate formation, as evidenced by QCM-D frequency shifts and ATR-FTIR data. At 10 μM, near the minimal inhibitory concentration, membrane disintegration becomes extensive, with the lipooligourea adopting orientations suggestive of random or tilted insertion geometries. These findings support a multimodal mechanism of action that transitions from surface association to full bilayer disruption in a concentration-dependent manner. The combined use of structural and dynamic measurements provides detailed insight into the physicochemical principles underlying lipooligourea-membrane interactions, offering a foundation for the rational design of membrane-active foldamer antibiotics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.